UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function

The Journal of biological chemistry, 2003-02, Vol.278 (9), p.7607-7616

2003

Volltextzugriff (PDF)

An Immune Response Manifested by the Common Occurrence of Annexins I and II Autoantibodies and High Circulating Levels of IL-6 in Lung Cancer

Proceedings of the National Academy of Sciences - PNAS, 2001-08, Vol.98 (17), p.9824-9829

2001

Volltextzugriff (PDF)

Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer

Clinical and translational science, 2022-01, Vol.15 (1), p.55-62

2022

Volltextzugriff (PDF)

A Distinct Repertoire of Autoantibodies in Hepatocellular Carcinoma Identified by Proteomic Analysis

Molecular & cellular proteomics, 2002-03, Vol.1 (3), p.197-203

2002

Volltextzugriff (PDF)

Preclinical Characterization of DPI-4452: A 68 Ga/ 177 Lu Theranostic Ligand for Carbonic Anhydrase IX

The Journal of nuclear medicine (1978), 2024-05, Vol.65 (5), p.761

2024

Volltextzugriff (PDF)

A database of protein expression in lung cancer

Proteomics (Weinheim), 2001-10, Vol.1 (10), p.1303-1319

2001

Volltextzugriff (PDF)

Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice

Genome biology, 2003-01, Vol.4 (7), p.R46-R46, Article R46

2003

Volltextzugriff (PDF)

Abstract 3443: The IAP antagonist xevinapant, in combination with high-dose cisplatin chemoradiotherapy, induces NF-kB and apoptotic pathway biomarkers in patients with high-risk locally advanced squamous cell carcinoma of the head and neck

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3443-3443

2022

Volltextzugriff (PDF)

Abstract 2088: The activity of the FGFR selective inhibitor Debio 1347 is correlated with high mRNA expression

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2088-2088

2017

Volltextzugriff (PDF)

Abstract 4881: Molecular screening of patients with FGFR alterations for phase 1 (ph1) study with the selective FGFR inhibitor Debio 1347

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4881-4881

2019

Volltextzugriff (PDF)

Abstract 4784: FGFR-selective inhibitor Debio 1347 induces tumor regressions in FGFR2-altered gastric cancer PDX models

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4784-4784

2016

Volltextzugriff (PDF)

Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer

Cancer research (Chicago, Ill.), 2001-11, Vol.61 (21), p.7908-7912

2001

Volltextzugriff (PDF)

Abstract 5001: Open-label, non-randomized, exploratory pre-operative window-of-opportunity trial to investigate the pharmacokinetics and pharmacodynamics of the smac mimetic Debio 1143 in patients with resectable squamous cell carcinoma of the head and neck

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.5001-5001

2019

Volltextzugriff (PDF)

Abstract CT202: Xevinapant plus avelumab in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC): Phase 1b dose-expansion results and exploratory biomarker analyses

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT202-CT202

2023

Volltextzugriff (PDF)

Protein based microarrays: A tool for probing the proteome of cancer cells and tissues

Proteomics (Weinheim), 2001-10, Vol.1 (10), p.1279-1287

2001

Volltextzugriff (PDF)

Scaled-Down Purification Protocol To Access Proteomic Analysis of 20S Proteasome from Human Tissue Samples: Comparison of Normal and Tumor Colorectal Cells

Journal of proteome research, 2008-07, Vol.7 (7), p.2852-2859

2008

Volltextzugriff (PDF)

Galectin-8: a complex sub-family of galectins (Review)

International journal of molecular medicine, 2001-09, Vol.8 (3), p.245

2001

Volltextzugriff (PDF)

A proteomic approach to the identification of lung cancer markers

Disease markers, 2001, Vol.17 (4), p.295-300

2001

Volltextzugriff (PDF)

Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell line

Gene, 2001-08, Vol.274 (1), p.253-262

2001

Volltextzugriff (PDF)

Identification of Tumor-Associated Antigens Using Proteomics

Technology in cancer research & treatment, 2002-08, Vol.1 (4), p.257-262

2002

Volltextzugriff (PDF)

A proteomic approach to the identification of lung cancer markers: Global strategies for disease detection and treatment: proteomics

Disease markers, 2001, Vol.17 (4), p.295-300

2001

Volltextzugriff (PDF)

Expression of Po66-CBP, a type-8 galectin, in different healthy, tumoral and peritumoral tissues

Anticancer research, 1999-11, Vol.19 (6B), p.5429

1999

Volltextzugriff (PDF)

Sodium butyrate induces growth inhibition and modulates galectin-8 expression in human lung carcinoma cells

Anticancer research, 2001-03, Vol.21 (2A), p.1049

2001

Volltextzugriff (PDF)

Immunohistochemical expression of the intracellular component of galectin-8 in squamous cell metaplasia of the bronchial epithelium in neoplastic and benign processes

Pathology, research and practice, 2001, Vol.197 (12), p.797-801

2001

Volltextzugriff (PDF)

Immunohistochemical Expression of the Intracellular Component of Galectin-8 in Squamous Cell Metaplasiaof the Bronchial Epitheliumin Neoplastic and Benign Processes

Pathology, research and practice, 2001, Vol.197 (12), p.797-801

2001

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Humans
(17)
Life Sciences & Biomedicine
(17)
Biochemistry & Molecular Biology
(6)
Lung Neoplasms - Metabolism
(6)
Tumor Cells, Cultured
(6)
Biochemical Research Methods
(5)
Biological And Medical Sciences
(5)
Blotting, Western
(5)
Cancer
(5)
Electrophoresis, Gel, Two-Dimensional
(5)
Female
(5)
Galectins
(5)
Medical Sciences
(5)
Tumors
(5)
Animals
(4)
Male
(4)
Oncology
(4)
Adenocarcinoma
(3)
Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function

An Immune Response Manifested by the Common Occurrence of Annexins I and II Autoantibodies and High Circulating Levels of IL-6 in Lung Cancer

Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer

A Distinct Repertoire of Autoantibodies in Hepatocellular Carcinoma Identified by Proteomic Analysis

Preclinical Characterization of DPI-4452: A 68 Ga/ 177 Lu Theranostic Ligand for Carbonic Anhydrase IX

A database of protein expression in lung cancer

Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice

Abstract 3443: The IAP antagonist xevinapant, in combination with high-dose cisplatin chemoradiotherapy, induces NF-kB and apoptotic pathway biomarkers in patients with high-risk locally advanced squamous cell carcinoma of the head and neck

Abstract 2088: The activity of the FGFR selective inhibitor Debio 1347 is correlated with high mRNA expression

Abstract 4881: Molecular screening of patients with FGFR alterations for phase 1 (ph1) study with the selective FGFR inhibitor Debio 1347

Abstract 4784: FGFR-selective inhibitor Debio 1347 induces tumor regressions in FGFR2-altered gastric cancer PDX models

Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer

Abstract 5001: Open-label, non-randomized, exploratory pre-operative window-of-opportunity trial to investigate the pharmacokinetics and pharmacodynamics of the smac mimetic Debio 1143 in patients with resectable squamous cell carcinoma of the head and neck

Abstract CT202: Xevinapant plus avelumab in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC): Phase 1b dose-expansion results and exploratory biomarker analyses

Protein based microarrays: A tool for probing the proteome of cancer cells and tissues

Scaled-Down Purification Protocol To Access Proteomic Analysis of 20S Proteasome from Human Tissue Samples: Comparison of Normal and Tumor Colorectal Cells

Galectin-8: a complex sub-family of galectins (Review)

A proteomic approach to the identification of lung cancer markers

Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell line

Identification of Tumor-Associated Antigens Using Proteomics

A proteomic approach to the identification of lung cancer markers: Global strategies for disease detection and treatment: proteomics

Expression of Po66-CBP, a type-8 galectin, in different healthy, tumoral and peritumoral tissues

Sodium butyrate induces growth inhibition and modulates galectin-8 expression in human lung carcinoma cells

Immunohistochemical expression of the intracellular component of galectin-8 in squamous cell metaplasia of the bronchial epithelium in neoplastic and benign processes

Immunohistochemical Expression of the Intracellular Component of Galectin-8 in Squamous Cell Metaplasiaof the Bronchial Epitheliumin Neoplastic and Benign Processes

Suchergebnisse filtern